BY BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
Novo Nordisk's rapid growth has made company President and CEO Lars Fruergaard Jørgensen publically air thoughts of increasing the company's 2025 ambitions, which were set just 2 years ago.
This includes the firm's goals for its obesity business, which has received a boost with unprecedented demand for the weight loss drug Wegovy, and the enormous sales of the diabetes drug Ozempic have also brought Novo Nordisk considerably closer to reaching some of its big 2025 milestones.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Cell Culture Scientist/Senior Scientist 
2 Sales Representatives and Product Specialists 
Director Global Engineering 
Process Manager 
Communications Consultant 
Clinical Trial Manager 
Senior IT Network Engineer 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Nordic Medical Affairs Manager 
Account Manager 
Director of Toxicology 
Client Talent Acquisition Specialist 
Vice President, Test & Characterisation 
(Senior) Drug Substance Specialist 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Procurement Process Excellence Specialist 
Key Account Manager, Europe and Asia